DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2022 年 06 月 13 日 2:00 下午 - 2022 年 06 月 13 日 5:00 下午

(Eastern Standard Time)

Defining the Clinical Questions of Interest: Why Everyone Developing a Protocol Should Understand Estimands!

Instructors

Rekha  Jhamnani, MD, MHS

Rekha Jhamnani, MD, MHS

Medical Officer, DNPDI, OND, CDER, FDA, United States

Rekha Jhamnani is a medical officer in the Division of Nonprescription Drugs at the FDA. She completed medical school at the George Washington University School of Medicine and internal medicine residency at Georgetown University Hospital. She then completed a fellowship in Allergy Immunology at the National Institutes of Health.

Khalid  Puthawala, MD

Khalid Puthawala, MD

Medical Officer, DPACC, OND, CDER , FDA, United States

Elisa  Gomez Valderas, MS

Elisa Gomez Valderas, MS

Senior Advisor, Eli Lilly and Company, United States

Munish  Mehra, PhD, MS, MSc

Munish Mehra, PhD, MS, MSc

Senior Principal Biostatistician and Executive Director Biometrics, Tigermed, United States

Munish Mehra serves as Executive Director and Principal Biostatistician at Tigermed US and as Managing Director at Tigermed, India Pvt. Ltd. During a career spanning 33 years, he gained extensive experience in the design, analysis and reporting of phase I-IV clinical trials across multiple therapeutic areas. He has represented sponsors at FDA Type B pre-IND, end of phase II and pre-NDA as well as Type C meetings as an expert biostatistician. Dr. Mehra is currently Chair of the DIA Clinical Research Community and has chaired sessions at several DIA Annual Meetings. He holds a PhD in biostatistics and a MS in computer science from the Univ. of KY, as well as a MS in mathematics from the Indian Institute of Technology.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。